H. Ahlman, A. Khorram-manesh, S. Jansson, B. Wangberg, O. Nilsson et al., Cytotoxic treatment of adrenocortical carcinoma, World Journal of Surgery, vol.52, issue.7, pp.927-933, 2001.
DOI : 10.1002/1097-0142(19930515)71:10<2900::AID-CNCR2820711003>3.0.CO;2-S

N. Al-khouri, H. Fessi, L. Roblot-treupel, J. P. Devissaguet, and F. Puisieux, An original procedure for preparation of nanocapsules of polyalkylcyanoacrylates for interfacial polymerization, Pharma Acta Helv, vol.61, pp.10-11, 1986.

E. Allemann, R. Gurny, and E. Doelker, Drug-loaded nanoparticles: Preparation methods and drug targeting tissues, Review Eur J Biopharm, vol.39, issue.5, pp.173-191, 1993.

B. Allolio, S. Hahner, D. Weismann, and M. Fassnacht, Management of adrenocortical carcinoma, Clinical Endocrinology, vol.111, issue.3, pp.273-287, 2004.
DOI : 10.1002/cncr.11084

G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison, A theoretical basis for a biopharmaceutic drug classification : The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-420, 1995.
DOI : 10.1023/A:1016212804288

G. L. Amidon, P. J. Sinko, and D. Fleisher, Estimating human oral fraction dose absorbed : A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds, Pharmaceutical Research, vol.05, issue.10, pp.651-654, 1988.
DOI : 10.1023/A:1015927004752

N. Ammoury, H. Fessi, J. P. Devissaguet, M. Allix, M. Plotkine et al., Effect on Cerebral Blood Flow of Orally Administered Indomethacin-loaded Poly(isobutylcyanoacrylate) and Poly(DL-lactide) Nanocapsules, Journal of Pharmacy and Pharmacology, vol.2, issue.8, pp.42-558, 1990.
DOI : 10.1002/art.1780310314

A. Andersen, A. A. Kasperlik-zaluska, and D. J. Warren, Determination of Mitotane (o,p`-DDD) and its Metabolites o,p`-DDA and o,p`-DDE in Plasma by High-Performance Liquid Chromatography, Therapeutic Drug Monitoring, vol.21, issue.3, pp.355-359, 1999.
DOI : 10.1097/00007691-199906000-00020

E. Andres, S. Vinzio, B. Goichot, and J. L. Schlienger, Mitotane-induced febrile pancytopenia: a first case report in paraneoplastic Cushing's syndrome, European Journal of Endocrinology, vol.144, issue.1, p.81, 2001.
DOI : 10.1530/eje.0.1440081

M. Aprahamian, C. Michel, W. Humbert, J. P. Devissaguet, and C. Damge, Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine, Biology of the Cell, vol.61, issue.1-2, pp.69-76, 1987.
DOI : 10.1111/j.1768-322X.1987.tb00571.x

H. Araya, M. Tomita, and M. Hayashi, The Novel Formulation Design of Self-emulsifying Drug Delivery Systems (SEDDS) Type O/W Microemulsion III: The Permeation Mechanism of a Poorly Water Soluble Drug Entrapped O/W Microemulsion in Rat Isolated Intestinal Membrane by the Ussing Chamber Method, Drug Metabolism and Pharmacokinetics, vol.21, issue.1, pp.45-53, 2006.
DOI : 10.2133/dmpk.21.45

P. Artursson, K. Palm, and K. Luthman, Caco-2 monolayers in experimental and theoretical predictions of drug transport, Adv Drug Deliv Rev, vol.46, pp.1-3, 2001.

E. Atef and A. A. Belmonte, Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS), European Journal of Pharmaceutical Sciences, vol.35, issue.4, pp.257-263, 2008.
DOI : 10.1016/j.ejps.2008.07.004

D. Attivi, P. Wehrle, N. Ubrich, C. Damge, M. Hoffman et al., Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology, Drug Development and Industrial Pharmacy, vol.31, issue.2, pp.179-189, 2005.
DOI : 10.3109/10837459609031423

D. Attwood, T. , and F. A. , Surfactant systems: Their chemistry, pharmacy and biology, 1983.
DOI : 10.1007/978-94-009-5775-6

J. Bacchetta and J. P. Droz, [practical use of o,p'ddd in adrenocortical carcinoma], Bull Cancer, vol.92, issue.3, pp.273-279, 2005.

P. Balakrishnan, B. J. Lee, D. H. Oh, J. O. Kim, M. J. Hong et al., Enhanced oral bioavailability of dexibuprofen by a novel solid sedds formulation Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'ddd) levels on the treatment of patients with adrenocortical carcinoma, Eur J Pharm Biopharm Cancer, vol.92, issue.6, pp.1385-1392, 2001.

R. Benecke, B. Vetter, and R. A. De-zeeuw, Rapid micromethod for the analysis of mitotane and its metabolite in plasma by gas chromatography with electron-capture detection, Journal of Chromatography B: Biomedical Sciences and Applications, vol.417, issue.2, pp.287-294, 1987.
DOI : 10.1016/0378-4347(87)80122-6

L. Z. Benet, T. Izumi, Y. Zhang, J. A. Silverman, and V. J. Wacher, Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery, Journal of Controlled Release, vol.62, issue.1-2, pp.25-31, 1999.
DOI : 10.1016/S0168-3659(99)00034-6

D. M. Bergenstal, R. Hertz, M. B. Lipsett, and R. H. Moy, Chemotherapy of adrenocortical cancer with o,p'-ddd (rothane) Annals of Internal Medicine, pp.672-682, 1960.

R. Bonacci, A. Gigliotti, E. Baudin, N. Wion-barbot, P. Emy et al., Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma, British Journal of Cancer, vol.78, issue.4, pp.546-549, 1998.
DOI : 10.1038/bjc.1998.530

I. Bravo-osuna, C. Vauthier, H. Chacun, and G. Ponchel, Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.69, issue.2, pp.436-444, 2008.
DOI : 10.1016/j.ejpb.2007.12.012

C. Brusewitz, A. Schendler, A. Funke, T. Wagner, and R. Lipp, Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds, International Journal of Pharmaceutics, vol.329, issue.1-2, pp.173-181, 2007.
DOI : 10.1016/j.ijpharm.2006.08.022

J. Carmichael, W. G. Degraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell, Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing, Cancer Res, vol.47, issue.4, pp.936-942, 1987.

A. Cazorla and F. Moncloa, Action of 1,1,Dichloro-2-p-chlorophenyl-2-o-chlorophenylethane on Dog Adrenal Cortex, Science, vol.136, issue.3510, p.47, 1962.
DOI : 10.1126/science.136.3510.47

R. K. Chang, J. C. Price, and C. W. Whitworth, Dissolution Characteristics of Polycaprolactone-Polylactide Microspheres of Chlorpromazine, Drug Development and Industrial Pharmacy, vol.13, issue.14, pp.2355-2380, 1986.
DOI : 10.1007/978-1-4684-7239-4_2

L. L. Clarke, A guide to Ussing chamber studies of mouse intestine, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.296, issue.6, pp.1151-1166, 2009.
DOI : 10.1113/jphysiol.2003.060046

E. T. Cole, D. Cade, and H. Benameur, Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration, Advanced Drug Delivery Reviews, vol.60, issue.6, pp.747-756, 2008.
DOI : 10.1016/j.addr.2007.09.009

P. P. Constantinides, Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects, Pharmaceutical Research, vol.12, issue.11, pp.1561-1572, 1995.
DOI : 10.1023/A:1016268311867

D. Q. Craig, D. Barker, D. Banning, and S. W. Booth, An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy, International Journal of Pharmaceutics, vol.114, issue.1, pp.103-110, 1995.
DOI : 10.1016/0378-5173(94)00222-Q

R. G. Crounse, Human Pharmacology of Griseofulvin: The Effect of Fat Intake on Gastrointestinal Absorption11From the Department of Dermatology, University of Miami Medical School, Miami, Florida., Journal of Investigative Dermatology, vol.37, issue.6, pp.529-533, 1961.
DOI : 10.1038/jid.1961.154

T. Dabros, A. Yeung, J. Masliyah, and J. Czarnecki, Emulsification through Area Contraction, Journal of Colloid and Interface Science, vol.210, issue.1, pp.222-224, 1999.
DOI : 10.1006/jcis.1998.5943

A. P. Dackiw, J. E. Lee, R. F. Gagel, and D. B. Evans, Adrenal cortical carcinoma, World Journal of Surgery, vol.12, issue.7, pp.914-926, 2001.
DOI : 10.1200/JCO.1994.12.6.1272

F. Dalençon, Y. Amjaud, C. Lafforgue, F. Derouin, and H. Fessi, Atovaquone and rifabutine-loaded nanocapsules: formulation studies, International Journal of Pharmaceutics, vol.153, issue.1, pp.127-130, 1997.
DOI : 10.1016/S0378-5173(97)00076-8

C. Damge, M. Aprahamian, H. Marchais, J. P. Benoit, and M. Pinget, Intestinal absorption of plaga microspheres in the rat, J Anat, vol.189, issue.3, pp.491-501, 1996.

W. W. Davis, R. R. Pfeiffer, and J. F. Quay, Normal and Promoted Gastrointestinal Absorption of Water-Soluble Substances I: Induced Rapidly Reversible Hyperabsorptive State in the Canine Fundic Stomach Pouch, Journal of Pharmaceutical Sciences, vol.59, issue.7, pp.960-963, 1970.
DOI : 10.1002/jps.2600590708

D. Francia, S. Pirro, E. Zappia, F. De-martino, F. Sprio et al., A new simple hplc method for measuring mitotane and its two principal metabolites tests in animals and mitotane-treated patients, J Chromatogr B Analyt Technol Biomed Life Sci, vol.837, pp.1-2, 2006.

G. Dickstein, C. Shechner, E. Arad, L. A. Best, and O. Nativ, Is there a role for low doses of mitotane (o,p'-ddd) as adjuvant therapy in adrenocortical carcinoma, J Clin Endocrinol Metab, vol.83, issue.9, pp.3100-3103, 1998.

M. Dittgen, M. Durrani, and K. Lehman, Acrylic polymers. A review of pharmaceutical applications, S.T.P. Pharma Sci, vol.7, pp.403-437, 1997.

J. H. Eldridge, J. A. Meulbroek, J. K. Staas, T. R. Tice, and R. M. Gilley, Vaccinecontaining biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response, Adv Exp Med Biol, vol.251, pp.191-202, 1989.

T. H. Ermak and P. J. Giannasca, Microparticle targeting to M cells, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.261-283, 1998.
DOI : 10.1016/S0169-409X(98)00043-X

H. Fessi, J. P. Devissaguet, F. Puisieux, and C. Thies, Procédé de préparation de systèmes colloïdaux dispersibles d'une substance sous forme de nanoparticules. Brevet français, pp.608-988, 1988.

J. K. Finnegan, H. B. Haag, and P. S. Larrson, Tissue Distribution and Elimination of DDD and DDT Following Oral Administration to Dogs and Rats., Experimental Biology and Medicine, vol.72, issue.2, pp.357-360, 1949.
DOI : 10.3181/00379727-72-17431

L. Gan-zuo and S. E. Friberg, Surfactant/cosurfactant association and emulsion stability, J Am Oil Chem Soc, vol.59, issue.12, pp.569-572, 1982.

T. Gershanik and S. Benita, Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs, European Journal of Pharmaceutics and Biopharmaceutics, vol.50, issue.1, pp.179-188, 2000.
DOI : 10.1016/S0939-6411(00)00089-8

T. Gershanik, S. Benzeno, and S. Benita, Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge, Pharmaceutical Research, vol.15, issue.6, pp.863-869, 1998.
DOI : 10.1023/A:1011968313933

S. Gibaud, N. Awwadi, C. Ducki, and A. Astier, Poly(??-caprolactone) and Eudragit?? microparticles containing fludrocortisone acetate, International Journal of Pharmaceutics, vol.269, issue.2, pp.491-508, 2004.
DOI : 10.1016/j.ijpharm.2003.09.040

URL : https://hal.archives-ouvertes.fr/hal-00399629

C. Goddeeris and G. Van-den-mooter, Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: Investigating the relationship between physicochemical characteristics and dissolution behaviour, European Journal of Pharmaceutical Sciences, vol.35, issue.1-2, pp.104-113, 2008.
DOI : 10.1016/j.ejps.2008.06.010

G. Ferreiro, M. Tillman, L. G. Hardee, G. Bodmeier, and R. , Alginate/poly-l-lysine microparticles for the intestinal delivery of antisense oligonucleotides, Pharmaceutical Research, vol.19, issue.6, pp.755-764, 2002.
DOI : 10.1023/A:1016188312399

M. Grove, A. Mullertz, J. L. Nielsen, and G. P. Pedersen, Bioavailability of seocalcitol, European Journal of Pharmaceutical Sciences, vol.28, issue.3, pp.233-242, 2006.
DOI : 10.1016/j.ejps.2006.02.005

M. Grove, A. Mullertz, G. P. Pedersen, and J. L. Nielsen, Bioavailability of seocalcitol, European Journal of Pharmaceutical Sciences, vol.31, issue.1, pp.8-15, 2007.
DOI : 10.1016/j.ejps.2007.01.007

H. Guenard, Circulation lymphatique. In : Physiologie Humaine. Paris : Pradel, pp.136-138, 1991.

S. K. Gupta, R. C. Manfro, S. J. Tomlanovich, J. G. Gambertoglio, M. R. Garovoy et al., Effect of Food on the Pharmacokinetics of Cyclosporine in Healthy Subjects Following Oral and Intravenous Administration, The Journal of Clinical Pharmacology, vol.17, issue.Suppl 5, pp.643-653, 1990.
DOI : 10.1023/A:1015939307478

S. S. Guterres, H. Fessi, G. Barratt, J. P. Devissaguet, and F. Puisieux, Poly (DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study, International Journal of Pharmaceutics, vol.113, issue.1, pp.57-63, 1995.
DOI : 10.1016/0378-5173(94)00177-7

H. R. Haak, K. M. Caekebeke-peerlinck, A. P. Van-seters, and E. Briet, Prolonged bleeding time due to mitotane therapy, European Journal of Cancer and Clinical Oncology, vol.27, issue.5, pp.638-641, 1991.
DOI : 10.1016/0277-5379(91)90233-4

H. R. Haak, J. Hermans, C. J. Van-de-velde, E. G. Lentjes, B. M. Goslings et al., Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients, British Journal of Cancer, vol.69, issue.5, pp.947-951, 1994.
DOI : 10.1038/bjc.1994.183

V. Hermansson, T. Cantillana, L. Hovander, A. Bergman, K. Ljungvall et al., Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p???-DDD (mitotane) in Minipigs, Cancer Chemotherapy and Pharmacology, vol.72, issue.352, pp.267-274, 2008.
DOI : 10.1016/j.scitotenv.2004.10.031

A. R. Hilgers, R. A. Conradi, and P. S. Burton, Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa, Pharmaceutical Research, vol.07, issue.9, pp.902-910, 1990.
DOI : 10.1023/A:1015937605100

A. Hsing, N. J. Co-chien, H. Mclaughlin, J. Fraumeni, and J. , Risk factors for adrenal cancer: An exploratory study, International Journal of Cancer, vol.39, issue.4, pp.432-436, 1996.
DOI : 10.1002/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y

B. Hubert, J. Atkinson, M. Guerret, M. Hoffman, J. P. Devissaguet et al., The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker, Pharmaceutical Research, vol.08, issue.6, pp.734-738, 1991.
DOI : 10.1023/A:1015897900363

A. J. Humberstone and W. N. Charman, Lipid-based vehicles for the oral delivery of poorly water soluble drugs, Advanced Drug Delivery Reviews, vol.25, issue.1, pp.103-128, 1997.
DOI : 10.1016/S0169-409X(96)00494-2

A. M. Hutter and D. E. Kayhoe, Adrenal cortical carcinoma, The American Journal of Medicine, vol.41, issue.4, pp.581-592, 1966.
DOI : 10.1016/0002-9343(66)90220-8

P. Jani, G. W. Halbert, J. Langridge, and A. T. Florence, Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency, Journal of Pharmacy and Pharmacology, vol.35, issue.12, pp.821-826, 1990.
DOI : 10.1146/annurev.me.35.020184.000523

P. U. Jani, D. E. Mccarthy, and A. T. Florence, Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose, International Journal of Pharmaceutics, vol.86, issue.2-3, pp.2-3, 1992.
DOI : 10.1016/0378-5173(92)90202-D

M. Jepson, N. Simmons, T. Savidge, P. James, and B. Hirst, Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells, Cell & Tissue Research, vol.162, issue.Suppl 2, pp.399-405, 1993.
DOI : 10.1093/infdis/162.4.896

T. Julianto, K. H. Yuen, and A. M. Noor, Improved bioavailability of vitamin E with a self emulsifying formulation, International Journal of Pharmaceutics, vol.200, issue.1, pp.53-57, 2000.
DOI : 10.1016/S0378-5173(00)00337-9

H. Kajii, T. Horie, M. Hayashi, and S. Awazu, Fluorescence Study of the Membrane-Perturbing Action of Sodium Caprylate as Related to Promotion of Drug Absorption, Journal of Pharmaceutical Sciences, vol.77, issue.5, pp.390-392, 1988.
DOI : 10.1002/jps.2600770506

B. K. Kang, J. S. Lee, S. K. Chon, S. Y. Jeong, S. H. Yuk et al., Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs, International Journal of Pharmaceutics, vol.274, issue.1-2, pp.1-2, 2004.
DOI : 10.1016/j.ijpharm.2003.12.028

W. T. Ke, S. Y. Lin, H. , H. Sheu, and M. T. , Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs, Journal of Controlled Release, vol.102, issue.2, pp.489-507, 2005.
DOI : 10.1016/j.jconrel.2004.10.030

S. M. Khoo, A. J. Humberstone, C. J. Porter, G. A. Edwards, and W. N. Charman, Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine, International Journal of Pharmaceutics, vol.167, issue.1-2, pp.155-164, 1998.
DOI : 10.1016/S0378-5173(98)00054-4

D. C. Kim, P. S. Burton, and R. T. Borchardt, A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa, Pharm Res, vol.10, issue.12, pp.1710-1714, 1993.

J. Y. Kim and Y. S. Ku, Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats, International Journal of Pharmaceutics, vol.194, issue.1, pp.81-89, 2000.
DOI : 10.1016/S0378-5173(99)00367-1

S. Kitamura, Y. Shimizu, Y. Shiraga, M. Yoshida, K. Sugihara et al., Reductive Metabolism of p,p'-DDT and o,p'-DDT by Rat Liver Cytochrome P450, Drug Metabolism and Disposition, vol.30, issue.2, p.113, 2002.
DOI : 10.1124/dmd.30.2.113

T. D. Klingberg, M. H. Pedersen, A. Cencic, and B. B. Budde, Application of Measurements of Transepithelial Electrical Resistance of Intestinal Epithelial Cell Monolayers To Evaluate Probiotic Activity, Applied and Environmental Microbiology, vol.71, issue.11, pp.71-7528, 2005.
DOI : 10.1128/AEM.71.11.7528-7530.2005

A. Kogan, E. Kesselman, D. Danino, A. Aserin, and N. Garti, Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions, Colloids and Surfaces B: Biointerfaces, vol.66, issue.1, pp.1-12, 2008.
DOI : 10.1016/j.colsurfb.2008.05.006

T. R. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, International Journal of Pharmaceutics, vol.212, issue.2, 2001.
DOI : 10.1016/S0378-5173(00)00614-1

G. A. Kossena, B. J. Boyd, C. J. Porter, and W. N. Charman, Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs, Journal of Pharmaceutical Sciences, vol.92, issue.3, pp.634-648, 2003.
DOI : 10.1002/jps.10329

H. Lennernas, K. Palm, U. Fagerholm, and P. Artursson, Comparison between active and passive drug transport in human intestinal epithelial (caco-2) cells in vitro and human jejunum in vivo, International Journal of Pharmaceutics, vol.127, issue.1, pp.103-107, 1996.
DOI : 10.1016/0378-5173(95)04204-0

J. C. Leroux, E. Allemann, E. Doelker, and R. Gurny, New approach for the preparation of nanoparticles by an emulsification-diffusion method, Eur J Pharm Biopharm, vol.41, issue.1, pp.14-18, 1995.

A. Loxley and B. Vincent, Preparation of Poly(methylmethacrylate) Microcapsules with Liquid Cores, Journal of Colloid and Interface Science, vol.208, issue.1, pp.49-62, 1998.
DOI : 10.1006/jcis.1998.5698

J. G. Magalhaes, I. Tattoli, and S. E. Girardin, The intestinal epithelial barrier: How to distinguish between the microbial flora and pathogens, Seminars in Immunology, vol.19, issue.2, pp.106-115, 2007.
DOI : 10.1016/j.smim.2006.12.006

K. Margulis-goshen and S. Magdassi, Formation of simvastatin nanoparticles from microemulsion, Nanomedicine: Nanotechnology, Biology and Medicine, vol.5, issue.3, 2008.
DOI : 10.1016/j.nano.2008.11.004

S. Mcclean, E. Prosser, E. Meehan, D. O-'malley, N. Clarke et al., Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia, European Journal of Pharmaceutical Sciences, vol.6, issue.2, pp.153-163, 1998.
DOI : 10.1016/S0928-0987(97)10007-0

M. Miyamoto, H. Natsume, S. Iwata, K. Ohtake, M. Yamaguchi et al., Improved nasal absorption of drugs using poly-l-arginine: effects of concentration and molecular weight of poly-l-arginine on the nasal absorption of fluorescein isothiocyanate???dextran in rats, European Journal of Pharmaceutics and Biopharmaceutics, vol.52, issue.1, pp.21-30, 2001.
DOI : 10.1016/S0939-6411(01)00149-7

D. Moinard-checot, Y. Chevalier, S. Briancon, L. Beney, and H. Fessi, Mechanism of nanocapsules formation by the emulsion???diffusion process, Journal of Colloid and Interface Science, vol.317, issue.2, pp.458-468, 2008.
DOI : 10.1016/j.jcis.2007.09.081

A. J. Moolenaar, H. Van-slooten, A. P. Van-seters, and D. Smeenk, Blood levels of o,p???-DDD following administration in various vehicles after a single dose and during long-term treatment, Cancer Chemotherapy and Pharmacology, vol.7, issue.1, pp.51-54, 1981.
DOI : 10.1007/BF00258213

R. H. Moy, Studies of the pharmacology of o,p'ddd in man, J Lab Clin Med, vol.58, pp.296-304, 1961.

M. Mullerad, G. Dickstein, C. Shechner, G. Meyer, B. Moskovitz et al., LONG-TERM FOLLOW-UP OF ADRENOCORTICAL CARCINOMA PATIENTS TREATED WITH ADJUVANT LOW-DOSE MITOTANE (O, P', -DDD), European Urology Supplements, vol.5, issue.2, pp.150-150, 2006.
DOI : 10.1016/S1569-9056(06)60515-0

A. A. Nelson and G. Woodard, Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(p-chlorophenyl)-1,1-dichloroethane (ddd or tde) Virchows Archiv fuer Pathologische Anatomie und Physiologie und fuer Klinische Medizin, pp.387-394, 1949.

O. Neuman, E. Bruckert, R. Chadarevian, N. Jacob, and G. Turpin, [hepatotoxicity of a synthetic cortisol antagonist: Op'ddd (mitotane)], Therapie, vol.56, issue.6, pp.793-797, 2001.

J. Nichols and G. Hennigar, (parachlorophenyl)-1, 1- dichloroethane, Studies on ddd, pp.2-310, 1957.

A. O. Nornoo, H. A. Zheng, L. B. Lopes, B. Johnson-restrepo, K. Kannan et al., Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies, European Journal of Pharmaceutics and Biopharmaceutics, vol.71, issue.2, pp.310-317, 2009.
DOI : 10.1016/j.ejpb.2008.08.015

D. A. Norris, N. Puri, and P. J. Sinko, The effect of physical barriers and properties on the oral absorption of particulates, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.135-154, 1998.
DOI : 10.1016/S0169-409X(98)00037-4

O. Donnell, P. B. Mcginity, and J. W. , Preparation of microspheres by the solvent evaporation technique, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.25-42, 1997.
DOI : 10.1016/S0169-409X(97)00049-5

O. Driscoll and C. M. , Lipid-based formulations for intestinal lymphatic delivery, European Journal of Pharmaceutical Sciences, vol.15, issue.5, pp.405-415, 2002.
DOI : 10.1016/S0928-0987(02)00051-9

V. Pade and S. Stavchansky, Link between drug absorption solubility and permeability measurements in Caco-2 cells, Journal of Pharmaceutical Sciences, vol.87, issue.12, pp.1604-1607, 1998.
DOI : 10.1021/js980111k

J. Pappo and T. H. Ermak, Uptake and translocation of fluorescent latex particles by rabbit peyer's patch follicle epithelium: A quantitative model for m cell uptake, Clin Exp Immunol, vol.76, issue.1, pp.144-148, 1989.

J. G. Park, B. S. Kramer, S. M. Steinberg, J. Carmichael, J. M. Collins et al., Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay, Cancer Res, issue.22, pp.47-5875, 1987.

S. Peltier, J. F. Oger, F. Lagarce, W. Couet, and J. P. Benoit, Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules, Pharmaceutical Research, vol.47, issue.6, pp.1243-1250, 2006.
DOI : 10.1111/j.1768-322X.1987.tb00571.x

N. A. Peppas and P. A. Buri, Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues, Journal of Controlled Release, vol.2, pp.257-275, 1985.
DOI : 10.1016/0168-3659(85)90050-1

C. Porter, A. M. Kaukonen, A. Taillardat-bertschinger, B. J. Boyd, J. M. O-'connor et al., Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine, Journal of Pharmaceutical Sciences, vol.93, issue.5, pp.1110-1121, 2004.
DOI : 10.1002/jps.20039

C. J. Porter, S. A. Charman, and W. N. Charman, Lymphatic Transport of Halofantrine in the Triple-Cannulated Anesthetized Rat Model: Effect of Lipid Vehicle Dispersion, Journal of Pharmaceutical Sciences, vol.85, issue.4, pp.351-356, 1996.
DOI : 10.1021/js950221g

C. W. Pouton, Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, International Journal of Pharmaceutics, vol.27, issue.2-3, pp.335-348, 1985.
DOI : 10.1016/0378-5173(85)90081-X

C. W. Pouton, Formulation of self-emulsifying drug delivery systems, Advanced Drug Delivery Reviews, vol.25, issue.1, pp.47-58, 1997.
DOI : 10.1016/S0169-409X(96)00490-5

C. W. Pouton, Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system, European Journal of Pharmaceutical Sciences, vol.29, issue.3-4, pp.3-4, 2006.
DOI : 10.1016/j.ejps.2006.04.016

C. W. Pouton and C. H. Porter, Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies, Advanced Drug Delivery Reviews, vol.60, issue.6, pp.625-637, 2008.
DOI : 10.1016/j.addr.2007.10.010

C. Prego, M. Fabre, D. Torres, and M. J. Alonso, Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery, Pharmaceutical Research, vol.25, issue.3, pp.549-556, 2006.
DOI : 10.1111/j.2042-7158.1990.tb07033.x

C. Prego, M. Garcia, D. Torres, and M. J. Alonso, Transmucosal macromolecular drug delivery, Journal of Controlled Release, vol.101, issue.1-3, pp.151-162, 2005.
DOI : 10.1016/j.jconrel.2004.07.030

F. Puisieux and L. Roblot-treupel, Vectorisation et vecteurs de médicaments, S.T.P. Pharma. Sciences, vol.5, pp.107-113, 1989.

Y. S. Quan, K. Hattori, E. Lundborg, T. Fujita, M. Murakami et al., Effectiveness and Toxicity Screening of Various Absorption Enhancers Using Caco-2 Cell Monolayers., Biological & Pharmaceutical Bulletin, vol.21, issue.6, pp.615-620, 1998.
DOI : 10.1248/bpb.21.615

D. Quintanar-guerrero, H. Fessi, E. Allemann, and E. Doelker, Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique, International Journal of Pharmaceutics, vol.143, issue.2, pp.133-141, 1996.
DOI : 10.1016/S0378-5173(96)04697-2

V. D. Reif, J. E. Sinsheimer, J. C. Ward, and D. E. Schteingart, Aromatic hydroxylation and alkyl oxidation in metabolism of mitotane (o,p'-ddd) in humans, J Pharm Sci, vol.63, issue.11, pp.1730-1736, 1974.

J. M. Rodrigues, H. Fessi, C. Bories, F. Puisieux, and J. P. Devissaguet, Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice, International Journal of Pharmaceutics, vol.126, issue.1-2, pp.253-260, 1995.
DOI : 10.1016/0378-5173(95)04135-4

S. Ruth, H. Attwood, D. Ktistis, G. Taylor, and C. J. , Phase studies and particle size analysis of oil-in-water phospholipid microemulsions, International Journal of Pharmaceutics, vol.116, issue.2, pp.253-261, 1995.
DOI : 10.1016/0378-5173(94)00316-W

E. Sanders and C. T. Ashworth, A study of particulate intestinal absorption and hepatocellular uptake, Experimental Cell Research, vol.22, pp.137-145, 1961.
DOI : 10.1016/0014-4827(61)90092-1

D. Scherer, F. C. Mooren, R. K. Kinne, and J. Kreuter, Permeability of PBCA Nanoparticles through Porcine Small Intestine, Journal of Drug Targeting, vol.7, issue.1, pp.21-27, 1993.
DOI : 10.1146/annurev.me.35.020184.000523

A. Serajuddin, P. C. Sheen, D. Mufson, D. F. Bernstein, and M. A. Augustine, Effect of Vehicle Amphiphilicity on the Dissolution and Bioavailability of a Poorly Water-Soluble Drug from Solid Dispersions, Journal of Pharmaceutical Sciences, vol.77, issue.5, pp.414-417, 1988.
DOI : 10.1002/jps.2600770512

X. Sha, G. Yan, Y. Wu, J. Li, and X. Fang, Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells, European Journal of Pharmaceutical Sciences, vol.24, issue.5, pp.477-486, 2005.
DOI : 10.1016/j.ejps.2005.01.001

X. Sha, G. Yan, Y. Wu, J. Li, and X. Fang, Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells, European Journal of Pharmaceutical Sciences, vol.24, issue.5, pp.477-486, 2005.
DOI : 10.1016/j.ejps.2005.01.001

S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar et al., Development and bioavailability assessment of ramipril nanoemulsion formulation, European Journal of Pharmaceutics and Biopharmaceutics, vol.66, issue.2, pp.227-243, 2007.
DOI : 10.1016/j.ejpb.2006.10.014

N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld, and A. W. Malick, Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, International Journal of Pharmaceutics, vol.106, issue.1, pp.15-23, 1994.
DOI : 10.1016/0378-5173(94)90271-2

Y. F. Shiau, Mechanism of intestinal fatty acid uptake in the rat: the role of an acidic microclimate., The Journal of Physiology, vol.421, issue.1, pp.463-474, 1990.
DOI : 10.1113/jphysiol.1990.sp017955

Y. Shono, H. Nishihara, Y. Matsuda, S. Furukawa, N. Okada et al., Modulation of Intestinal P-Glycoprotein Function by Cremophor EL and Other Surfactants by an In Vitro Diffusion Chamber Method Using the Isolated Rat Intestinal Membranes, Journal of Pharmaceutical Sciences, vol.93, issue.4, pp.877-885, 2004.
DOI : 10.1002/jps.20017

K. Sonaje, Y. Lin, J. Juang, S. Wey, C. Chen et al., In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery, Biomaterials, vol.30, issue.12, pp.30-2329, 2009.
DOI : 10.1016/j.biomaterials.2008.12.066

R. G. Strickley, Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004.
DOI : 10.1023/B:PHAM.0000016235.32639.23

B. Tarr and S. H. Yalkowsky, Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size, Pharmaceutical Research, vol.06, issue.1, pp.40-43, 1989.
DOI : 10.1023/A:1015843517762

M. Terzolo, A. Angeli, M. Fassnacht, F. Daffara, L. Tauchmanova et al., Adjuvant Mitotane Treatment for Adrenocortical Carcinoma, New England Journal of Medicine, vol.356, issue.23, pp.356-2372, 2007.
DOI : 10.1056/NEJMoa063360

M. Terzolo, A. Pia, A. Berruti, G. Osella, A. Ali et al., Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.6, pp.2234-2238, 2000.
DOI : 10.1210/jc.85.6.2234

Y. Touitou, A. Bogdan, J. C. Legrand, and P. Desgrez, [metabolism of o,p'-ddd (mitotane) in human and animals. Actual notions and practical deductions (author's transl)], Ann Endocrinol, vol.38, issue.1, pp.13-25, 1977.

P. J. Trainer and M. Besser, Cushing's syndrome. Therapy directed at the adrenal glands, 1994.

M. Trotta, M. Gallarate, F. Pattarino, and S. Morel, Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions, Journal of Controlled Release, vol.76, issue.1-2, pp.119-128, 2001.
DOI : 10.1016/S0168-3659(01)00432-1

W. Tullner, Adrenal atrophy effects in animals In : Proceedings of the chemotherapy conference on ortho para' ddd. Edited by le broder, sk carter, bethesda, Cancer therapy Evaluation Branch, N. C. I, pp.6-16, 1970.

K. Uekama, F. Hirayama, and T. Irie, Cyclodextrin Drug Carrier Systems, Chemical Reviews, vol.98, issue.5, pp.98-2045, 1998.
DOI : 10.1021/cr970025p

F. J. Van-natta, J. W. Hill, and W. H. Carruthers, ??-Caprolactone and its Polymers, Journal of the American Chemical Society, vol.56, issue.2, pp.455-459, 1934.
DOI : 10.1021/ja01317a053

H. Van-slooten, A. J. Moolenaar, A. P. Van-seters, and D. Smeenk, The treatment of adrenocortical carcinoma with o,p???-DDD: Prognostic simplications of serum level monitoring, European Journal of Cancer and Clinical Oncology, vol.20, issue.1, 1984.
DOI : 10.1016/0277-5379(84)90033-6

J. Vonderscher and A. Meinzer, Rationale for the development of sandimmune neoral, Transplant Proc, vol.26, issue.5, pp.2925-2927, 1994.

E. Z. Wallace, J. N. Silverstein, L. S. Villadolid, and S. Weisenfeld, Cushing's Syndrome Due to Adrenocortical Hyperplasia, New England Journal of Medicine, vol.265, issue.22, pp.1088-1093, 1961.
DOI : 10.1056/NEJM196111302652204

A. D. Watson, A. Rijnberk, and A. J. Moolenaar, Systemic availability of o,p'-ddd in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism, Res Vet Sci, vol.43, issue.2, pp.160-165, 1987.

G. Wedermeyer, Dechlorination of 1,1,1-trichloro-2, 2-bis (p-chlorophelyl) ethane by aerobacter aerogenes i. Metabolic products, Appl. Microbiol, vol.15, issue.3, pp.569-574, 1967.

P. Wils, A. Warnery, V. Phung-ba, and D. Scherman, Differentiated intestinal epithelial cell lines asin vitro models for predicting the intestinal absorption of drugs, Cell Biology and Toxicology, vol.269, issue.5-6, pp.5-6, 1994.
DOI : 10.1007/BF00755788

M. Yang, F. Cui, B. You, J. You, L. Wang et al., A novel phdependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs, J Control Release, vol.98, issue.2, pp.219-229, 2004.

Y. Yang, P. J. Faustino, D. A. Volpe, D. Christopher, C. D. Ellison et al., Biopharmaceutics Classification of Selected ??-Blockers:?? Solubility and Permeability Class Membership, Molecular Pharmaceutics, vol.4, issue.4, pp.608-614, 2007.
DOI : 10.1021/mp070028i

S. Yee, In vitro permeability across caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth, Pharmaceutical Research, vol.14, issue.6, pp.763-766, 1997.
DOI : 10.1023/A:1012102522787

H. Yoshikawa, K. Takada, and S. Muranishi, Molecular weight dependence of permselectivity to rat small intestinal blood-lymph barrier for exogenous macromolecules absorbed from lumen., Journal of Pharmacobio-Dynamics, vol.7, issue.1, pp.1-6, 1984.
DOI : 10.1248/bpb1978.7.1

P. Zhang, Y. Liu, N. Feng, and J. Xu, Preparation and evaluation of self-microemulsifying drug delivery system of oridonin, International Journal of Pharmaceutics, vol.355, issue.1-2, pp.269-276, 2008.
DOI : 10.1016/j.ijpharm.2007.12.026